Dr. Lisa Nezneski developed and refined the Orphan Drug Support Program while serving as a Consultant. Her consulting career spans over three decades, serving small rural hospitals to university teaching hospitals. Well versed in the ever changing Orphan Drug Universe, she brings a wealth of experience to each client to individualize, understand, and solve Orphan Drug Issues. She is dedicated to bringing a heart-centered approach to each client.


At 340B Orphan Drug Solutions, we believe in the transformative power of having a turnkey system to manage Orphan Drugs in Expansion Entities. Our mission is simple: to empower Expansion Entities with strategic solutions that not only capture Orphan Drug savings, but also provide a customized Orphan Drug portfolio for your facility with less manual work that drives tangible growth and success. What sets us apart is not just our expertise but our commitment to understanding the unique DNA of each entity. It’s not just a list. It’s a partnership.

Our vision is to be the catalyst for transformative 340B Orphan Drug solutions that redefine industry standards. We envision a future where Expansion Entities not only capture outpatient savings, but also allow for the growth in Specialty, Contract, and Infusion Pharmacies.
Our mission is to deliver strategic and impactful 340B Orphan Drug solutions that propel Expansion Entities to new heights of success. We are committed to leveraging our expertise in data-driven insights, customizing all aspects of Orphan Drug Management, and reducing the time and effort each facility has to invest.


© 2026 340B Orphan Drug Solutions. All rights reserved.